万方数据
万方数据
万方数据
万方数据
从VEGF在湿性年龄相关性黄斑变性发病过程中的作用机制看抗
VEGF药物治疗
作者：李筱荣， 刘巨平， LI Xiao-rong， LIU Ju-ping
作者单位：300384, 天津医科大学眼科中心
刊名：
中华实验眼科杂志
英文刊名：Chinese Journal of Experimental Ophthalmology
年，卷(期)：2012,30(4)
被引用次数：1次
参考文献(33条)
1.Congdon N;O' Colmain B;Klaver CC Causes and prevalence of visual impairment among adults in the United States 2004
2.Wong TY;Chong EW;Wong WL Prevalence and causes of low vision and blindness in an urban malay population:the Singapore Malay Eye Study 2008
3.Klein R;Klein BE;Knudtson MD Fifteen-year cumulative incidence of age-related macular degeneration:the Beaver Dam Eye Study 2007
4.Pepple K;Mruthyunjaya P Retinal pigment epithelial detachments in age-related macular
degeneration:classification and therapeutic options[外文期刊] 2011
5.Spilsbury K;Garrett KL;Shen WY Overexpression of vascular endothelial growth factor (VEGF)in the retinal pigment epithelium leads to the development of choroidal neovascularization[外文期刊] 2000
6.Clauss M;Gerlach M;Gerlach H Vascular permeability factor:a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity,and promotes monocyte migration[外文期刊] 1990
7.Dvorak HF;Nagy JA;Feng D Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis 1999
8.Ferrara N Molecular and biological properties of vascular endothelial growth factor 1999
9.Pechan P;Rubin H;Lukason M Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization[外文期刊] 2009(1)
10.Lukason M;DuFresne E;Rubin H Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule[外文期刊] 2011
11.Schonthaler HB;Huggenberger R;Wculek SK Systemic antiVEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis[外文期刊] 2009
12.Riheiro SC;Vargas FS;Antonangelo L Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion 2009
13.Saravia M;Zapata G;Ferraiolo P Anti-VEGF monoclonal antibodyinduced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis 2009
14.Gragoudas ES;Adamis AP;Cunningham ET Jr Pegaptanib for neovascular age-related macular degeneration 2004
15.Chakravarthy U;Adamis AP;Cunningham ET Jr Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration 2006
16.Rosenfeld PJ;Brown DM;Heier JS Ranibizumab for neovascular age-related macular degeneration 2006
17.Heier JS;Antoszyk AN;Pavan PR Ranibizumab for treatment of neovascular age-related macular degeneration:a phase Ⅰ/Ⅱ multicenter,controlled,multidose study 2006
18.Boyer DS;Heier JS;Brown DM A Phase Ⅲ b study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration[外文期刊] 2009(9)
19.Brown DM;Kaiser PK;Michels M Ranibizumab versus verteporfin for neovascular age-related macular degeneration [外文期刊] 2006
20.Brown DM;Michels M;Kaiser PK Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration:Two-year results of the ANCHOR study 2009
21.Dadgostar H;Ventura AA;Chung JY Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration[外文期刊] 2009(9)
22.Tufail A;Patel PJ;Egan C Bevacizumab for neovascular age related macular degeneration (ABC Trial):multicentre randomised double masked study[外文期刊] 2010
23.Potter M J;Claudio CC;Szabo SM A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration:the VIA study[外文期刊] 2010
24.Sacu S;Michels S;Prager F Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone:longterm results 2009
25.Subramanian ML;Ness S;Abedi G Bevacizumab vs ranibizumab for age-related macular degeneration:early results of a prospective double-masked,randomized clinical trial[外文期刊] 2009
26.Subramanian ML;Abedi G;Ness S Bevacizumab vs ranibizumab for age-related macular degeneration:1-year outcomes of a prospective,double-masked randomised clinical trial[外文期刊] 2010
27.Schouten JS;La Heij EC;Webers CA A systematic review on the effect of bevacizumab in exudative age-related macular degeneration[外文期刊] 2009(1)
28.Group CR;Martin DF;Maguire MG Ranibizumab and bevacizumab for neovascular age-related macular degeneration 2011
29.Abouammoh M;Sharma S Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration[外文期刊] 2011
30.Dixon JA;Oliver SC;Olson JL VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration [外文期刊] 2009
31.Mousa SA;Mousa SS Current status of vascular endothelial growth factor inhibition in age-related macular degeneration 2010
32.Singerman L Combination therapy using the small interfering RNA bevasiranib 2009
33.Fong B;Barkhoudarian G;Pezeshkian P The molecular biology and novel treatments of vestibular schwannomas[外文期刊] 2011
引证文献(2条)
1.胡伟伟.范清林.尼钢钢.张玲.黄辉.宋礼华人血管内皮生长因子受体-Fc在DG44细胞中的表达及其生物活性[期刊论文]-中国生物制品学杂志 2013(8)
2.金淑萍.袁援生年龄相关性黄斑变性的治疗进展[期刊论文]-医学综述 2014(2)
本文链接：https://www.doczj.com/doc/de18760224.html,/Periodical_ykyj201204001.aspx